Cargando…

Previous cervical cytology and high-risk human papillomavirus testing in a cohort of patients with invasive cervical carcinoma in Shandong Province, China

BACKGROUND: Currently, available data regarding previous cervical cytology and high-risk human papillomavirus (hrHPV) test results to detect invasive cervical cancer are limited and controversial in China. Therefore, this retrospective study in a population of Chinese women with invasive cervical ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Liran, Xie, Fengxiang, Wang, Xinguo, Peng, Dezhi, Bi, Chunrui, Jiang, Lingbo, Zhao, Dongman, Tian, Xinxin, Qi, Debo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491257/
https://www.ncbi.nlm.nih.gov/pubmed/28662160
http://dx.doi.org/10.1371/journal.pone.0180618
_version_ 1783247112103788544
author Zhang, Liran
Xie, Fengxiang
Wang, Xinguo
Peng, Dezhi
Bi, Chunrui
Jiang, Lingbo
Zhao, Dongman
Tian, Xinxin
Qi, Debo
author_facet Zhang, Liran
Xie, Fengxiang
Wang, Xinguo
Peng, Dezhi
Bi, Chunrui
Jiang, Lingbo
Zhao, Dongman
Tian, Xinxin
Qi, Debo
author_sort Zhang, Liran
collection PubMed
description BACKGROUND: Currently, available data regarding previous cervical cytology and high-risk human papillomavirus (hrHPV) test results to detect invasive cervical cancer are limited and controversial in China. Therefore, this retrospective study in a population of Chinese women with invasive cervical carcinoma aimed to gain further insight into the roles of cytology and hrHPV testing in cervical cancer screening. METHODS: A total of 1214 cases with a histological diagnosis of invasive cervical cancer were retrieved from the Pathology Database of Jinan KingMed Diagnostics (JKD) over a 5-year period. Previous cytology and hrHPV test results of 469 patients carried out within the year before cancer diagnosis were documented. RESULTS: A higher percentage of patients who had undergone prior screening had micro-invasive cervical carcinoma than patients who had no prior screening (25.4% vs. 12.1%, P < 0.001). Of the 469 patients with available prior screening results, 170 had cytology alone, 161 had hrHPV testing alone, and 138 had both cytology and hrHPV testing. There was a significantly lower percentage of hrHPV-positive cases with adenocarcinoma than with squamous cell carcinoma (77.8% vs. 96.4%, P = 0.001). The hrHPV test showed a significantly higher sensitivity than cytology alone (94.4% vs. 85.3%, P = 0.006). The overall sensitivity of the combination of cytology and hrHPV testing (98.6%) was much higher than that of cytology alone (P < 0.001) but only marginally higher than that of hrHPV testing alone (P = 0.058). CONCLUSIONS: The results revealed that prior cervical screening can detect a significantly larger number of micro-invasive cervical cancers. The hrHPV test can provide a more sensitive and efficient strategy than cytology alone. As the addition of cytology to hrHPV testing can only marginally increase the efficiency of the hrHPV test, hrHPV testing should be used as the primary screening approach, especially in the low-resource settings of China.
format Online
Article
Text
id pubmed-5491257
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-54912572017-07-18 Previous cervical cytology and high-risk human papillomavirus testing in a cohort of patients with invasive cervical carcinoma in Shandong Province, China Zhang, Liran Xie, Fengxiang Wang, Xinguo Peng, Dezhi Bi, Chunrui Jiang, Lingbo Zhao, Dongman Tian, Xinxin Qi, Debo PLoS One Research Article BACKGROUND: Currently, available data regarding previous cervical cytology and high-risk human papillomavirus (hrHPV) test results to detect invasive cervical cancer are limited and controversial in China. Therefore, this retrospective study in a population of Chinese women with invasive cervical carcinoma aimed to gain further insight into the roles of cytology and hrHPV testing in cervical cancer screening. METHODS: A total of 1214 cases with a histological diagnosis of invasive cervical cancer were retrieved from the Pathology Database of Jinan KingMed Diagnostics (JKD) over a 5-year period. Previous cytology and hrHPV test results of 469 patients carried out within the year before cancer diagnosis were documented. RESULTS: A higher percentage of patients who had undergone prior screening had micro-invasive cervical carcinoma than patients who had no prior screening (25.4% vs. 12.1%, P < 0.001). Of the 469 patients with available prior screening results, 170 had cytology alone, 161 had hrHPV testing alone, and 138 had both cytology and hrHPV testing. There was a significantly lower percentage of hrHPV-positive cases with adenocarcinoma than with squamous cell carcinoma (77.8% vs. 96.4%, P = 0.001). The hrHPV test showed a significantly higher sensitivity than cytology alone (94.4% vs. 85.3%, P = 0.006). The overall sensitivity of the combination of cytology and hrHPV testing (98.6%) was much higher than that of cytology alone (P < 0.001) but only marginally higher than that of hrHPV testing alone (P = 0.058). CONCLUSIONS: The results revealed that prior cervical screening can detect a significantly larger number of micro-invasive cervical cancers. The hrHPV test can provide a more sensitive and efficient strategy than cytology alone. As the addition of cytology to hrHPV testing can only marginally increase the efficiency of the hrHPV test, hrHPV testing should be used as the primary screening approach, especially in the low-resource settings of China. Public Library of Science 2017-06-29 /pmc/articles/PMC5491257/ /pubmed/28662160 http://dx.doi.org/10.1371/journal.pone.0180618 Text en © 2017 Zhang et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Zhang, Liran
Xie, Fengxiang
Wang, Xinguo
Peng, Dezhi
Bi, Chunrui
Jiang, Lingbo
Zhao, Dongman
Tian, Xinxin
Qi, Debo
Previous cervical cytology and high-risk human papillomavirus testing in a cohort of patients with invasive cervical carcinoma in Shandong Province, China
title Previous cervical cytology and high-risk human papillomavirus testing in a cohort of patients with invasive cervical carcinoma in Shandong Province, China
title_full Previous cervical cytology and high-risk human papillomavirus testing in a cohort of patients with invasive cervical carcinoma in Shandong Province, China
title_fullStr Previous cervical cytology and high-risk human papillomavirus testing in a cohort of patients with invasive cervical carcinoma in Shandong Province, China
title_full_unstemmed Previous cervical cytology and high-risk human papillomavirus testing in a cohort of patients with invasive cervical carcinoma in Shandong Province, China
title_short Previous cervical cytology and high-risk human papillomavirus testing in a cohort of patients with invasive cervical carcinoma in Shandong Province, China
title_sort previous cervical cytology and high-risk human papillomavirus testing in a cohort of patients with invasive cervical carcinoma in shandong province, china
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491257/
https://www.ncbi.nlm.nih.gov/pubmed/28662160
http://dx.doi.org/10.1371/journal.pone.0180618
work_keys_str_mv AT zhangliran previouscervicalcytologyandhighriskhumanpapillomavirustestinginacohortofpatientswithinvasivecervicalcarcinomainshandongprovincechina
AT xiefengxiang previouscervicalcytologyandhighriskhumanpapillomavirustestinginacohortofpatientswithinvasivecervicalcarcinomainshandongprovincechina
AT wangxinguo previouscervicalcytologyandhighriskhumanpapillomavirustestinginacohortofpatientswithinvasivecervicalcarcinomainshandongprovincechina
AT pengdezhi previouscervicalcytologyandhighriskhumanpapillomavirustestinginacohortofpatientswithinvasivecervicalcarcinomainshandongprovincechina
AT bichunrui previouscervicalcytologyandhighriskhumanpapillomavirustestinginacohortofpatientswithinvasivecervicalcarcinomainshandongprovincechina
AT jianglingbo previouscervicalcytologyandhighriskhumanpapillomavirustestinginacohortofpatientswithinvasivecervicalcarcinomainshandongprovincechina
AT zhaodongman previouscervicalcytologyandhighriskhumanpapillomavirustestinginacohortofpatientswithinvasivecervicalcarcinomainshandongprovincechina
AT tianxinxin previouscervicalcytologyandhighriskhumanpapillomavirustestinginacohortofpatientswithinvasivecervicalcarcinomainshandongprovincechina
AT qidebo previouscervicalcytologyandhighriskhumanpapillomavirustestinginacohortofpatientswithinvasivecervicalcarcinomainshandongprovincechina